Aramco’s Prosperity7 powers AI drug firm Insilico’s $95M round

Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” The firm has raised $35 million on the heels of its last tranche in June, bringing its total Series D...

Hong Kong’s AI drug discovery firm Insilico closes $60M Series D

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. It’s a sign that certain investors are continuing to bet on emerging biotechnologies — which...

Hong Kong’s AI drug discovery firm Insilico closes $60M Series D

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. It’s a sign that certain investors are continuing to bet on emerging biotechnologies — which...

Temasek’s Pavilion Capital backs South Korean AI chip maker Rebellions with $50M investment

Global venture capital firms are pouring money into the semiconductor startups developing the next generation of chips. Semiconductors, which have become a valued asset, are used in virtually almost every industry, including 5G networks, automation, the Internet of...